Spots Global Cancer Trial Database for unspecified adult solid tumor
Every month we try and update this database with for unspecified adult solid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors | NCT02324621 | Unspecified Adu... | Oral ONC201 pharmacological... laboratory biom... | 18 Years - | Rutgers, The State University of New Jersey | |
| Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | NCT00938457 | Unspecified Adu... | stereotactic ra... implanted fiduc... cone-beam compu... | 18 Years - 120 Years | Mayo Clinic | |
| PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors | NCT02049593 | Metastatic Canc... Unspecified Adu... | PARP inhibitor ... temozolomide irinotecan hydr... pharmacological... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer | NCT00553059 | Chemotherapy-in... Unspecified Adu... | dexamethasone dronabinol palonosetron hy... placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors | NCT00390156 | Unspecified Adu... | bevacizumab cyclophosphamid... imatinib | 18 Years - | University of California, San Francisco | |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | NCT01843413 | Tumors Metastat... Unspecified Adu... | stereotactic ra... quality-of-life... cognitive asses... | 18 Years - | Case Comprehensive Cancer Center | |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | NCT00037804 | Unspecified Adu... Chemotherapy Liver Dysfuncti... Neoplasms, Soli... | Irinotecan | 18 Years - | Pfizer | |
| Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | NCT00477607 | Ototoxicity Unspecified Adu... | alpha-lipoic ac... Audiology laboratory biom... Placebo | 18 Years - | VA Office of Research and Development | |
| LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors | NCT00052273 | Adult Solid Tumor | capecitabine enzastaurin hyd... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | NCT00037804 | Unspecified Adu... Chemotherapy Liver Dysfuncti... Neoplasms, Soli... | Irinotecan | 18 Years - | Pfizer | |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | NCT01843413 | Tumors Metastat... Unspecified Adu... | stereotactic ra... quality-of-life... cognitive asses... | 18 Years - | Case Comprehensive Cancer Center | |
| Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy | NCT03789773 | Unspecified Adu... | Millimeter-Wave... | 18 Years - | University of Southern California | |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | NCT00037804 | Unspecified Adu... Chemotherapy Liver Dysfuncti... Neoplasms, Soli... | Irinotecan | 18 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
